Bonesupport Holding AB
BONEX
ISIN SE0009858152 / Valor 36497524
Bonesupport Holding AB
UMushroom community rating:
About company
Bonesupport Holding AB is a Scandinavian company specializing in orthobiologics, focusing on the development and marketing of CERAMENT®, a line of radiopaque injectable osteoconductive and drug-eluting bioceramic products. These products are designed to heal bone defects by remodeling to host bone within six to twelve months. The company's innovative solutions are utilized in various orthopedic and trauma applications, providing effective treatment options for bone infections and other skeletal conditions. Bonesupport's offerings are distinguished by their ability to enhance bone healing and integrate with the body's natural processes, positioning the company as a significant player in the orthobiologics market.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (06.08.2024):
Net Sales Growth
Bonesupport Holding AB reported a significant increase in net sales for Q1 2024, with a 54 percent rise compared to the same period last year. The net sales amounted to SEK 184.4 million, up from SEK 119.7 million in Q1 2023.
Segment Performance
The North America segment of Bonesupport Holding AB showed remarkable growth, with sales increasing by 65 percent. Similarly, the Europe & Rest of the World segment experienced a 27 percent rise in sales during Q1 2024.
Gross Margin
Bonesupport Holding AB achieved a gross margin of 92.6 percent in Q1 2024, an improvement from the 90.5 percent gross margin reported in the same quarter of the previous year.
Operating Results
The operating result before the effects of the Group’s incentive programs for Bonesupport Holding AB was SEK 41.6 million in Q1 2024, a substantial increase from SEK 4.6 million in Q1 2023. The reported operating result was SEK 32.3 million, up from SEK 0.8 million.
Earnings Per Share
Bonesupport Holding AB's earnings per share before and after dilution were SEK 0.33 in Q1 2024, compared to SEK 0.00 in the same quarter of the previous year, indicating a positive shift in profitability.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
2121 M
Market cap (USD)
159,390
Daily traded volume (Shares)
322 / 313.6
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
